In addition, miR-1269b can also affect the progress of cancer through a series of regulatory methods, such as directly targeting the downstream gene METTL3 or by targeting SVEP1 and PTEN to drive the PI3K/AKT signaling pathway, thereby mediating tumor recurrence and metastasis. This evidence concerns the gene AKT1 and neoplasm.